Google spinoff Isomorphic Labs is in a race to shake up the long, painful road to cancer-beating drugs
AI-generated summary Isomorphic Labs plans to use its new drug design engine to develop medicines for cancer and other conditions. Max Jaderberg says the company intends to engineer molecules so patients can receive the minimum necessary drug amount.